Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Evaluating Dapagliflozin’s Effect on Immune Activity in Patients with Membranous Nephropathy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study of Trastuzumab Deruxtecan, Rilvegostomig, and Pembrolizumab for Advanced or Recurrent Endometrial Cancer in HER2-Positive Patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Austria Belgium Denmark Finland France Germany +7
  • Study on Preventing CMV Infection in Low-Risk Kidney Transplant Patients Using Ganciclovir and Valganciclovir

    Recruiting

    1 1 1 1
    Investigated diseases:
    Spain
  • Study of Bimekizumab for Children and Adolescents with Moderate to Severe Hidradenitis Suppurativa

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Poland
  • Study on the Safety and Effectiveness of Telisotuzumab Adizutecan and Drug Combination for Patients with Metastatic Colorectal Cancer

    Recruiting

    1 1 1
    Austria Czechia France Greece Italy Spain
  • Study of MZE829 capsules for adults with APOL1 kidney disease and protein in urine

    Recruiting

    1 1
    Investigated drugs:
    France
  • Study on the Effects of Vosoritide for Children with Idiopathic Short Stature

    Recruiting

    1 1
    Investigated drugs:
    France Germany Italy
  • Study on Lutikizumab and Risankizumab for Adults with Active Psoriatic Arthritis

    Recruiting

    1 1
    Investigated drugs:
    Czechia France Hungary Poland
  • Study of NBTXR3 and Cetuximab for Elderly Patients with Advanced Head and Neck Cancer Ineligible for Platinum Chemotherapy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +4
  • Study of Pucotenlimab with Becotatug Vedotin versus Becotatug Vedotin alone for patients with locally advanced head and neck squamous cell carcinoma

    Recruiting

    1 1
    Investigated drugs:
    France